(Q35789319)

10 August 2017

Combination viroimmunotherapy with checkpoint inhibition to treat glioma, based on location-specific tumor profiling (English)

1 reference

10 August 2017

11

Peter Selby

0 references

Alan Melcher

13

Alan Melcher

0 references

Susan C. Short

Susan Short

10

0 references

Ian F. Parney

Ian F Parney

9

0 references

Elizabeth Ilett

Elizabeth Ilett

12

0 references

author name string

Julia V Cockle

1

1 reference

10 August 2017

Karishma Rajani

2

1 reference

10 August 2017

Shane Zaidi

3

1 reference

10 August 2017

Timothy Kottke

4

1 reference

10 August 2017

Jill Thompson

5

1 reference

10 August 2017

Rosa Maria Diaz

6

1 reference

10 August 2017

Kevin Shim

7

1 reference

10 August 2017

Tim Peterson

8

1 reference

10 August 2017

Richard Vile

14

1 reference

10 August 2017

language of work or name

1 reference

26 September 2015

1 reference

10 August 2017

1 reference

10 August 2017

18

1 reference

10 August 2017

4

1 reference

10 August 2017

518-527

1 reference

Talimogene Laherparepvec Improves Durable Response Rate in Patients With Advanced Melanoma

10 August 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4799678

The evolution of checkpoint blockade as a cancer therapy: what's here, what's next?

27 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4799678

Mutated BRAF Emerges as a Major Effector of Recurrence in a Murine Melanoma Model After Treatment With Immunomodulatory Agents

27 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4799678

Immunotherapy for primary brain tumors: no longer a matter of privilege

27 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4799678

The profile of tumor antigens which can be targeted by immunotherapy depends upon the tumor's anatomical site

27 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4799678

Going viral with cancer immunotherapy

27 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4799678

27 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4799678

Functional cloning of recurrence-specific antigens identifies molecular targets to treat tumor relapse

27 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4799678

Exploiting CTLA-4, PD-1 and PD-L1 to reactivate the host immune response against cancer.

27 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4799678

Combining immunotherapy and targeted therapies in cancer treatment

27 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4799678

Broad antigenic coverage induced by vaccination with virus-based cDNA libraries cures established tumors

27 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4799678

Sipuleucel-T immunotherapy for castration-resistant prostate cancer

27 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4799678

Improved Survival with Ipilimumab in Patients with Metastatic Melanoma

27 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4799678

Genetically engineered vesicular stomatitis virus in gene therapy: application for treatment of malignant disease

27 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4799678

Expression of co-stimulatory molecules by tumor cells decreases tumorigenicity but may also reduce systemic antitumor immunity

27 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4799678

CTLA-4 and PD-L1 checkpoint blockade enhances oncolytic measles virus therapy

27 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4799678

The blockade of immune checkpoints in cancer immunotherapy

25 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4799678

Using virally expressed melanoma cDNA libraries to identify tumor-associated antigens that cure melanoma

25 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4799678

Glioblastoma survival in the United States before and during the temozolomide era.

25 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4799678

Use of an orthotopic xenograft model for assessing the effect of epidermal growth factor receptor amplification on glioblastoma radiation response.

25 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4799678

Induction of hsp70-mediated Th17 autoimmunity can be exploited as immunotherapy for metastatic prostate cancer

25 September 2018

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/26409567

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Identifiers

DOI

10.1093/NEUONC/NOV173

1 reference

Dimensions Publication ID

10 August 2017

10.1093/NEUONC/NOV173

0 references

1059934991

0 references

Microsoft Academic ID

0 references

1 reference

10 August 2017

1 reference